New research from Queen Mary University of London (QMUL) reveals taking aspirin can significantly reduce the risk of developing – and dying from – the major cancers of the digestive tract, i.e. bowel, stomach and oesophageal cancer. For the first time, scientists have reviewed all the available evidence from many studies and clinical trials assessing […]
Category: Cancer
Death rates from pancreatic cancer are rising while rates for all other cancers, except female lung cancer, continue to fall in Europe
Pancreatic cancer is the only cancer for which deaths are predicted to increase in men and women rather than decrease in 2014 and beyond, according to a comprehensive study published in the leading cancer journal Annals of Oncology [1]. The study by researchers in Italy and Switzerland shows that the proportion of deaths due to […]
Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer
Vienna, Austria: Men with prostate cancer that is small and confined to the prostate gland but that is at risk of growing and spreading, do better if they are treated with radiotherapy combined with androgen deprivation therapy, which lowers their levels of the male hormone, testosterone, according to new research. The findings, presented at the […]
Increased risk of developing lung cancer after radiotherapy for breast cancer
Vienna, Austria: Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy […]
The prognosis of tumours that are positive for human papilloma virus in head and neck cancers varies according to their site
Vienna, Austria: Patients with cancer of the throat and who are positive for the Human Papilloma virus (HPV+) have a good prognosis, but until now the effect of being HPV+ on the prognosis of tumours located elsewhere in the head and neck was unknown. Danish researchers have now shown that HPV status appears to have […]
New test developed to detect men at high risk of prostate cancer recurrence
Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna heard on Saturday. Professor Robert Bristow told the conference that […]
Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes
Vienna, Austria: The use of permanent brachytherapy, a procedure where radioactive sources are placed inside the prostate, into or near to the tumour, preserves erectile function in approximately 50% of patients with prostate cancer, a researcher told the ESTRO 33 congress. Brachytherapy works by giving a high dose of radiotherapy directly to the tumour, but […]
Audit of NHS Breast Screening Programme reveals significant variations between hospitals in adverse outcomes for treatment of ductal carcinoma in situ
Glasgow, UK: Analysis of data from the UK NHS Breast Screening Programme has shown significant variations in the outcomes of treatment for women with ductal carcinoma in situ (DCIS) between UK hospitals. Dr Jeremy Thomas, a consultant pathologist at the Western General Hospital, Edinburgh, UK, told the European Breast Cancer Conference on Friday that although […]
Results from NHS Breast Screening Programme study finds a third of women might benefit from more frequent mammograms
Glasgow, UK: A study of over 50,000 women participating in the UK NHS Breast Screening Programme has found that, while three-yearly screening intervals are appropriate for the majority of women, approximately one third of women are at higher risk of developing cancer and might benefit from more frequent mammograms. Professor Gareth Evans, from the University […]
Harms outweigh benefits for women aged 70 and over in national breast cancer screening programmes
Glasgow, UK: Extending national breast cancer screening programmes to women over the age of 70 does not result in a decrease in the numbers of cancers detected at advanced stages, according to new research from The Netherlands. Instead, researchers told the European Breast Cancer Conference that their findings suggest that extending screening programmes to older […]